Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1

Status

Completed 2Active not recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 65Genitourinary 65Gastrointestinal 49Thoracic 48Other hematologic neoplasm 47Breast 41Plasma cell 37Head & Neck 25CNS 22Sarcoma 20Myeloid 16Gynecologic 16Dermatologic 13Other solid neoplasm 10Endocrine 7Tumor-Agnostic 3NET 3Classical hematology 1

Conditions

Neoplasms 2Neoplasms, Unknown Primary 1Neoplasm Metastasis 1Carcinoma 1

Interventions

pembrolizumab 1Specimen Handling 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Tumor-Agnostic × 30 days × Clear all
NCT04585269 2026-05-20

Bright IDEAS - Young Adults Problem-Solving Skills Training

Rutgers, The State University of New Jersey

Phase NA Completed
344 enrolled 13 charts
Tumor-Agnostic

Neoplasms

NCT03752333 2026-05-04

CUPem

Imperial College London

Phase 2 Completed
35 enrolled 11 charts
Tumor-Agnostic

Carcinoma, Neoplasms, Neoplasms, Unknown Primary

NCT03872427 2026-05-04

Testing Whether Cancers With Specific Mutations Respond Better to Glutaminase Inhibitor, Telaglenastat Hydrochloride, Anti-Cancer Treatment, BeGIN Study

National Cancer Institute (NCI)

Phase 2 Active not recruiting
54 enrolled 12 charts
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡